353 related articles for article (PubMed ID: 3725133)
1. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage.
Tettenborn D; Dycka J; Volberg E; Düdden P
Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():84-6. PubMed ID: 4010871
[TBL] [Abstract][Full Text] [Related]
3. [Cerebral vasospasm following subarachnoid hemorrhage. New aspects of diagnosis and therapy].
Voth D
Zentralbl Neurochir; 1987; 48(2):89-101. PubMed ID: 3314267
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experiences with nimodipine (Bay e 9736)].
Russegger L; Kostron H; Twerdy K; Grunert V
Neurochirurgia (Stuttg); 1984 Mar; 27(2):39-43. PubMed ID: 6728094
[TBL] [Abstract][Full Text] [Related]
5. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
6. [Cardiorespiratory problems in the use of calcium antagonists for vasospasm prophylaxis in subarachnoid hemorrhage].
Guggenberger H; Kottler B; Heuser D
Anaesthesist; 1986 Jul; 35(7):429-32. PubMed ID: 3752488
[TBL] [Abstract][Full Text] [Related]
7. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats.
Tanaka K; Gotoh F; Muramatsu F; Fukuuchi Y; Okayasu H; Suzuki N; Kobari M
Arzneimittelforschung; 1982; 32(12):1529-34. PubMed ID: 6891592
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.
Adams HP
Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
[TBL] [Abstract][Full Text] [Related]
10. Calcium antagonists and vasospasm.
Meyer FB
Neurosurg Clin N Am; 1990 Apr; 1(2):367-76. PubMed ID: 2136149
[TBL] [Abstract][Full Text] [Related]
11. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
Di Mascio R; Marchioli R; Tognoni G
Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
[TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage.
Hongo K; Kobayashi S
Neurol Res; 1993 Aug; 15(4):218-24. PubMed ID: 8105400
[TBL] [Abstract][Full Text] [Related]
13. Update on calcium antagonists in cerebrovascular diseases.
Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
[TBL] [Abstract][Full Text] [Related]
14. New aspects of calcium antagonists for treatment of cerebrovascular disease.
Hennerici MG
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S59-63. PubMed ID: 1725006
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with nimodipine in the prophylaxis of neurological deficits after subarachnoid hemorrhage.
Kazner E; Sprung C; Adelt D; Ammerer HP; Karnick R; Baumann H; Böker DK; Grotenhuis JA; Jaksche H; Istaitih AR
Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():110-3. PubMed ID: 4010865
[TBL] [Abstract][Full Text] [Related]
16. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
Kazda S; Garthoff B; Krause HP; Schlossmann K
Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
[TBL] [Abstract][Full Text] [Related]
17. Nimodipine in subarachnoid hemorrhage.
DiPalma JR
Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity.
Kazda S
Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():70-3. PubMed ID: 4010868
[TBL] [Abstract][Full Text] [Related]
19. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.
Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
Clin Hemorheol Microcirc; 2003; 29(3-4):337-44. PubMed ID: 14724359
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective properties of calcium-channel blockers.
Zornow MH; Prough DS
New Horiz; 1996 Feb; 4(1):107-14. PubMed ID: 8689265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
